Summary of Study ST001937
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001226. The data can be accessed directly via it's Project DOI: 10.21228/M87H88 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST001937 |
| Study Title | Comprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules |
| Study Summary | This study found evidence of early metabolic alterations that can distinguish SPNs from healthy controls, but not for benign and malignant SPNs (lung cancer in stage I), highlighting that malignant SPNs less than 3 cm in diameter are most likely lung cancer at some early stage that does not affect blood circulation. Benign SPNs seldom require excessive treatment, and the strategy to detecting and managing malignant SPNs is to perform periodic radiographic examinations and, if operable, bring patients to surgery as quickly as feasible to prevent cancer cells from entering the circulation. |
| Institute | China Pharmaceutical University |
| Last Name | Zhou |
| First Name | Wei |
| Address | NO.639 Longmian avenue, Jiangning District, Nanjing city, Jiangsu Province, China |
| wzhou@cpu.edu.cn | |
| Phone | 18351893063 |
| Submit Date | 2021-09-11 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | raw(Thermo) |
| Analysis Type Detail | GC-MS/LC-MS |
| Release Date | 2023-09-11 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR001226 |
| Project DOI: | doi: 10.21228/M87H88 |
| Project Title: | Comprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules |
| Project Summary: | A discovery set and four validation sets were used in our study to confirm and validate the results for differentiating benign from malignant SPNs. |
| Institute: | China Pharmaceutical University |
| Last Name: | Zhou |
| First Name: | Wei |
| Address: | NO.639 Longmian Avenue, Jiangning District, Nanjing city, Jiangsu Province, China |
| Email: | wzhou@cpu.edu.cn |
| Phone: | 18351893063 |
